Tate & Lyle Yönetim

Yönetim kriter kontrolleri 3/4

Tate & Lyle CEO'su Nick Hampton, Apr2018 tarihinde atandı, in görev süresi 6.58 yıldır. in toplam yıllık tazminatı £ 2.59M olup, şirket hissesi ve opsiyonları dahil olmak üzere 28% maaş ve 72% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.39% ine doğrudan sahiptir ve bu hisseler € 15.30M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.2 yıl ve 3.7 yıldır.

Anahtar bilgiler

Nick Hampton

İcra Kurulu Başkanı

UK£2.6m

Toplam tazminat

CEO maaş yüzdesi	28.0%
CEO görev süresi	6.6yrs
CEO sahipliği	0.4%
Yönetim ortalama görev süresi	6.2yrs
Yönetim Kurulu ortalama görev süresi	3.7yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Nick Hampton'un ücretlendirmesi Tate & Lyle'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	UK£155m
Jun 30 2024	n/a	n/a	UK£167m
Mar 31 2024	UK£3m	UK£723k	UK£179m
Sep 30 2023	n/a	n/a	UK£165m
Jun 30 2023	n/a	n/a	UK£146m
Mar 31 2023	UK£3m	UK£712k	UK£127m
Sep 30 2022	n/a	n/a	UK£70m
Jun 30 2022	n/a	n/a	UK£48m
Mar 31 2022	UK£2m	UK£685k	UK£26m
Sep 30 2021	n/a	n/a	UK£56m
Jun 30 2021	n/a	n/a	UK£73m
Mar 31 2021	UK£3m	UK£665k	UK£89m
Dec 31 2020	n/a	n/a	UK£124m
Sep 30 2020	n/a	n/a	UK£159m
Jun 30 2020	n/a	n/a	UK£202m
Mar 31 2020	UK£2m	UK£665k	UK£245m
Dec 31 2019	n/a	n/a	UK£238m
Sep 30 2019	n/a	n/a	UK£231m
Jun 30 2019	n/a	n/a	UK£206m
Mar 31 2019	UK£3m	UK£665k	UK£181m
Sep 30 2018	n/a	n/a	UK£220m
Jun 30 2018	n/a	n/a	UK£242m
Mar 31 2018	UK£3m	UK£526k	UK£263m

Tazminat ve Piyasa: Nick 'nin toplam tazminatı ($USD 3.26M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.92M ).

Tazminat ve Kazançlar: Nick 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Nick Hampton (57 yo)

6.6yrs

Görev süresi

UK£2,585,000

Tazminat

Mr. Anthony Nicholas Seymour Hampton, also known as Nick, MA (Hons), has been Chief Executive of Tate & Lyle plc since April 1, 2018 and has been its Director since September 2014. He joined Tate & Lyle pl...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Anthony Nicholas Hampton	CEO & Executive Director	6.6yrs	UK£2.59m	0.39% € 15.3m
Sarah Kuijlaars	CFO & Director	less than a year	Veri yok	0.0045% € 175.1k
Melissa Law	President of Global Operations	7.2yrs	Veri yok	0.015% € 573.3k
Christopher Marsh	Vice President of Investor Relations	no data	Veri yok	Veri yok
Lindsay Beardsell	Executive VP & General Counsel	6.2yrs	Veri yok	Veri yok
Tamsin Vine	Chief Human Resources Officer	1.9yrs	Veri yok	Veri yok
Rowan Adams	Executive Vice President of Corporate Affairs	10yrs	Veri yok	0.057% € 2.2m
Andrew Taylor	President of Asia	7.2yrs	Veri yok	Veri yok
Victoria Grant	President of Innovation & Commercial Development	4yrs	Veri yok	Veri yok
Kavita Karnik	Global Head of Nutrition	no data	Veri yok	Veri yok
William Magee	President of North America	3.1yrs	Veri yok	0.0052% € 204.4k
Jan-Jaap Der Bij	Senior Vice President of Global Environment	no data	Veri yok	Veri yok

6.2yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim: TLYB 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Anthony Nicholas Hampton	CEO & Executive Director	10.2yrs	UK£2.59m	0.39% € 15.3m
Sarah Kuijlaars	CFO & Director	less than a year	Veri yok	0.0045% € 175.1k
Lars Frederiksen	Independent Non-Executive Director	8.6yrs	UK£69.00k	0.0029% € 112.6k
Warren Tucker	Independent Non-Executive Director	6yrs	UK£183.00k	0.0022% € 87.2k
Kimberly Nelson	Lead Independent Non-Executive Director	5.3yrs	UK£72.00k	0.0013% € 48.9k
Jeffrey Carr	Independent Non-Executive Director	less than a year	Veri yok	0.0022% € 87.5k
Glenn Fish	Director	no data	Veri yok	Veri yok
David Lovat Hearn	Independent Chairman	less than a year	UK£89.00k	0.0043% € 166.9k
Sybella Stanley	Independent Non-Executive Director	8.6yrs	UK£84.00k	0.00096% € 37.5k
Patricia Corsi	Independent Non-Executive Director	3.5yrs	UK£69.00k	Veri yok
Isabelle Esser	Independent Non-Executive Director	2.4yrs	UK£69.00k	Veri yok
Kwok Cheung	Independent Non-Executive Director	3.8yrs	UK£69.00k	0.0011% € 43.8k

3.7yrs

Ortalama Görev Süresi

61.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: TLYB 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.7 yıldır).

Tate & Lyle Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Tate & Lyle plc Announces Board Changes

Tate & Lyle plc Announces Company Secretary Changes

Tate & Lyle plc, Annual General Meeting, Jul 25, 2024

High number of new directors

Tate & Lyle plc Announces Resignation of Dawn Allen, Chief Financial Officer

Tate & Lyle plc Appoints Jeffrey Carrwill as Non-Executive Director and as Member of the Audit and Nominations Committees on 1 April 2024

Recent updates

First half dividend of UK£0.064 announced

First half 2025 earnings released: EPS: UK£0.18 (vs UK£0.26 in 1H 2024)

Tate & Lyle Surges on Takeover Talk

Investor sentiment improves as stock rises 19%

Tate & Lyle plc Announces Board Changes

Tate & Lyle plc Announces Company Secretary Changes

KPS Capital Partners, LP completed the acquisition of remaining 49.7% stake in Primary Products Investments LLC from Tate & Lyle plc (LSE:TATE).

Tate & Lyle plc (LSE:TATE) announces an Equity Buyback for £215 million worth of its shares.

Upcoming dividend of UK£0.13 per share

Tate & Lyle plc, Annual General Meeting, Jul 25, 2024

Full year 2024 earnings released: EPS: UK£0.45 (vs UK£0.31 in FY 2023)

First half dividend of UK£0.13 announced

Tate & Lyle plc Recommends Final Dividend for the Year 2024, Payable on August 2, 2024

High number of new directors

Tate & Lyle plc Announces Resignation of Dawn Allen, Chief Financial Officer

Tate & Lyle plc(LSE:TATE) dropped from FTSE All-World Index (USD)

Tate & Lyle plc Appoints Jeffrey Carrwill as Non-Executive Director and as Member of the Audit and Nominations Committees on 1 April 2024

Tate & Lyle plc Provides Revenue Guidance for the Year Ending 31 March 2024

Tate & Lyle plc to Report Q2, 2025 Results on Nov 07, 2024

Tate & Lyle plc to Report First Half, 2025 Results on Nov 09, 2024

Upcoming dividend of UK£0.062 per share at 2.9% yield

Tate & Lyle plc Declares an Interim Dividend

First half 2024 earnings released: EPS: UK£0.26 (vs UK£0.14 in 1H 2023)

Tate & Lyle plc Announces Directorate Changes

Tate & Lyle plc Announces Appointment of Warren Tucker as Interim Chairman to the Board

Tate & Lyle plc to Report Q2, 2024 Results on Nov 09, 2023

Tate & Lyle plc Announces Directorate Change

Upcoming dividend of UK£0.13 per share at 2.5% yield

Tate & Lyle plc, Annual General Meeting, Jul 27, 2023

Now 22% undervalued

Full year 2023 earnings released: EPS: UK£0.31 (vs UK£0.065 in FY 2022)

Tate & Lyle plc Recommends Final Dividend, Payable on 2 August 2023

Tate & Lyle plc to Report Fiscal Year 2023 Results on May 25, 2023

Tate & Lyle plc Reaffirms Earnings Guidance for the Year Ending 31 March 2023

Upcoming dividend of UK£0.054 per share

First half 2023 earnings released: EPS: UK£0.14 (vs UK£0.03 in 1H 2022)

First half 2023 earnings released: EPS: UK£0.14 (vs UK£0.03 in 1H 2022)

Tate & Lyle plc Approves Interim Dividend for the Six Months to 30 September 2022, Payable on 4 January 2023

Tate & Lyle plc to Report First Half, 2023 Results on Nov 10, 2022

Tate & Lyle plc to Report First Half, 2023 Results on Nov 10, 2022

High number of new directors

High number of new directors

Upcoming dividend of UK£0.13 per share

Tate & Lyle plc, Annual General Meeting, Jul 28, 2022

Now 20% undervalued after recent price drop

Full year 2022 earnings released

Tate & Lyle plc (LSE:TATE) completed the acquisition of Guangdong Quantum Hi-Tech Microecology Medical Co., Ltd. from Chempartner Pharmatech Co., Ltd. (SZSE:300149).

Tate & Lyle plc Proposes Final Dividend for the Financial Year 2022, Payable on 5 August 2022

Upcoming dividend of UK£1.07 per share

Tate & Lyle plc, Annual General Meeting, Apr 26, 2022

Tate & Lyle plc (LSE:TATE) signed an agreement to acquire Guangdong Quantum Hi-Tech Microecology Medical Co., Ltd. from Chempartner Pharmatech Co., Ltd. (SZSE:300149) for $237 million.

Tate & Lyle plc to Report Fiscal Year 2022 Results on Jun 09, 2022

Tate & Lyle plc Appoints Dawn Allen to the Position of Chief Financial Office, Effective from May 16, 2022

Tate & Lyle plc (LSE:TATE) acquired an unknown minority stake in Zymtronix Catalytic Systems Inc.

Upcoming dividend of UK£0.09 per share

First half 2022 earnings released: EPS UK£0.026 (vs UK£0.097 in 1H 2021)

Independent Non-Executive Chairman recently bought €80k worth of stock

Independent Non Executive Director Anne Minto has left the company

Full year 2021 earnings released: EPS UK£0.55 (vs UK£0.53 in FY 2020)

Upcoming dividend of UK£0.22 per share

Full year 2021 earnings released: EPS UK£0.55 (vs UK£0.53 in FY 2020)

Tate & Lyle plc Recommends Final Dividend for the Full Year 2021

Tate & Lyle Exploring Separation of Two Businesses

Independent Non-Executive Director & Chairman of Research Advisory Group Ajai Puri has left the company

CFO & Director has left the company

Tate & Lyle plc, Annual General Meeting, Jul 29, 2021

Ajai Puri to Retire from the Tate & Lyle PLC's Board on 31 March 2021

New 90-day high: €8.50

Tate & Lyle plc (LSE:TATE) completed the acquisition of 85% shareholding in Chaodee Modified Starch Co., Ltd.